Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Brain Behav Immun. 2011 Oct 12;26(2):311–317. doi: 10.1016/j.bbi.2011.09.016

Table 2.

Effects of intraperitoneal administration of vehicle (saline), 48/80 and 48/80 following sodium cromoglycate (SCG+48/80) on the level of mast cells degranulation within the intracranial dura mater, bladder and hind paw skin.

Degranulation level (%)

Treatment Dura mater (n=4) Hind paw skin (n=4) Bladder (n=5)
Vehicle 16±7 12±3 18±5
48/80 58±12*# 69±6*# 71±13*#
SCG+48/80 23±6 28±11 31±9
*

p < 0.05, Kruskal-Wallis test, 48/80 vs. vehicle,

#

p < 0.05 48/80 vs. SCG+48/80.